baricitinib
Showing 26 - 50 of 78
Nakajo-Nishimura Syndrome, Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome,
Active, not recruiting
- Nakajo-Nishimura Syndrome
- +3 more
- Baricitinib
-
Hiroshima-shi, Hiroshima-ken, Japan
- +4 more
Oct 14, 2021
COVID-19 Pneumonia Trial in Bangladesh (Baricitinib, Dexamethasone, Remdesivir)
Recruiting
- COVID-19 Pneumonia
- Baricitinib
- +2 more
-
Comilla, Bangladesh
- +6 more
Aug 25, 2021
Molecular Signatures in Inflammatory Skin Disease
Recruiting
- Atopic Dermatitis
- Psoriasis
- Ustekinumab
- +9 more
-
Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022
COVID-19 Trial in Aurora (Baricitinib)
Withdrawn
- COVID-19
- Baricitinib
-
Aurora, ColoradoUniversity of Colorado, Denver
Mar 3, 2021
Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Baricitinib, Hydroxychloroquine, Placebo
Terminated
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Baricitinib
- +2 more
-
Los Angeles, California
- +1 more
May 21, 2021
Rheumatoid Arthritis, Bone Density, Finger Joints Trial in Erlangen (Baricitinib)
Unknown status
- Rheumatoid Arthritis
- +2 more
- Baricitinib
-
Erlangen, Bavaria, GermanyUniversitiy Hospital Erlangen
Jan 14, 2021
Covid19, Covid-19 ARDS Trial in Dinajpur (Remdesivir, Baricitinib, Tocilizumab)
Recruiting
- Covid19
- Covid-19 ARDS
- Remdesivir
- +2 more
-
Dinajpur, BangladeshM. Abdur Rahim Medical College Hospital
Dec 31, 2020
Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Recruiting
- Systemic Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +65 more
Jan 18, 2023
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Rheumatoid Arthritis Trial in United States (Active Stimulation, Sham Stimulation, Baricitinib)
Recruiting
- Rheumatoid Arthritis
- Active Stimulation
- +3 more
-
Anniston, Alabama
- +3 more
Oct 25, 2021
Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE), Juvenile Dermatomyositis (JDM),
No longer available
- Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE)
- +3 more
- Baricitinib
-
Bethesda, Maryland
- +2 more
Apr 6, 2022
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)
Recruiting
- Atopic Dermatitis
- Baricitinib
- +2 more
-
Caba, Buenos Aires, Argentina
- +85 more
Nov 4, 2022
Atopic Dermatitis Trial in Canada, Puerto Rico, United States (Baricitinib)
Completed
- Atopic Dermatitis
- Baricitinib
-
Birmingham, Alabama
- +73 more
Jul 22, 2022
Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Completed
- Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +85 more
Sep 8, 2022
Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib)
Recruiting
- Juvenile Idiopathic Arthritis
- Baricitinib
-
Rosario, Santa Fe, Argentina
- +95 more
Jan 18, 2023
Rheumatoid Arthritis Trial in United States (Baricitinib, TNF Inhibitor)
Recruiting
- Rheumatoid Arthritis
- Baricitinib
- TNF Inhibitor
-
Flagstaff, Arizona
- +108 more
Jan 17, 2023
Primary Biliary Cholangitis Trial in Puerto Rico, United States (Baricitinib, Placebo)
Terminated
- Primary Biliary Cholangitis
- Baricitinib
- Placebo
-
Coronado, California
- +11 more
Sep 18, 2020
Alopecia Areata Trial in Worldwide (Baricitinib, Placebo)
Active, not recruiting
- Alopecia Areata
- Baricitinib
- Placebo
-
Birmingham, Alabama
- +74 more
Feb 2, 2022
Pharmacological Action Trial in Prato (Baricitinib)
Unknown status
- Pharmacological Action
- Baricitinib
-
Prato, Tuscany, ItalyFabrizio Cantini
Apr 19, 2020
Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)
Active, not recruiting
- Atopic Dermatitis
- Baricitinib
- +2 more
-
Graz, Steiermark, Austria
- +102 more
May 25, 2022
Alopecia Areata Trial in Worldwide (Baricitinib, Placebo)
Active, not recruiting
- Alopecia Areata
- Baricitinib
- Placebo
-
Birmingham, Alabama
- +97 more
Jan 24, 2022
Atopic Dermatitis Trial in Canada, Puerto Rico, United States (Baricitinib, Placebo)
Completed
- Atopic Dermatitis
- Baricitinib
- Placebo
-
Birmingham, Alabama
- +80 more
Aug 17, 2021
Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)
Active, not recruiting
- Atopic Dermatitis
- Baricitinib
- Placebo
-
Caba, Buenos Aires, Argentina
- +184 more
Jun 7, 2022